Skip to main content
Caplight Logo









CergenX

CergenX

Private
DublinHealthcare & Life Scienceshttps://www.cergenx.com/

Last Round

Grant

Nov 28, 2023

Total Funding Raised

$8.14M

Company Overview

CergenX is a medtech company that provides an artificial intelligence (AI)-based clinical assessment platform designed to support early detection and monitoring of brain injury in newborns.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

neonatal brain monitoringAI diagnosticsmedical AIEEG analysisEEGnewborn brain injuryMedTechmedical deviceneurotechpoint of care diagnosticsclinical decision supportFDA breakthrough devicecloud AI platformelectroencephalogram

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CergenX Comparables

Compare CergenX with similar companies based on industry and business-model similarity.

CergenX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NeuroBell
94%
Wavelet Medical
82%
Ceribell
68%

CergenX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 28, 2023
Private PlacementJul 7, 2023
SeedJul 5, 2022

Key People

Founding team and executive leadership

Geraldine Boylan

Co-Founder And Chief Scientific Officer

Founding Team

Jason Mowles

CEO & Co-Founder

Founding Team

CergenX Investors

Notable investors and investment history

CergenX investors
InvestorRounds
Disruptive Technologies Innovation FundGrant
Enterprise IrelandPrivate Placement, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 23, 2026

    Grew 73% QoQ, from 11 to 19 employees.

  • Jan 1, 2026

    Monthly visitors increased 322% MoM.

Recent news

Latest coverage and updates

  • attends_eventAug 31, 2026

    Cergenx Ltd attended event MDR/IVDR 2.0 Summit on Aug 31st '26.

CergenX Filings

Explore SEC and related filing metadata, where available.

CergenX filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CergenX's valuation, stock price, and market status.

Is CergenX a public or private company?

CergenX is a private company.

What is the current stock price of CergenX?

CergenX is a private company with no public stock price. No recent secondary market data is available.

How much is CergenX worth (valuation)?

Valuation information for CergenX is not publicly available.

Can I buy CergenX stock?

CergenX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CergenX's last funding round?

CergenX's most recent funding round was Grant on November 28, 2023.

Who are the main investors in CergenX?

Key investors in CergenX include Disruptive Technologies Innovation Fund, Enterprise Ireland.

Will CergenX IPO soon?

No public IPO plans have been announced for CergenX.

How can I track CergenX secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CergenX's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDublin
Employee Range18
Year Founded2021
Last FundingNov 28, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?